Michael B. Jebsen
2020
In 2020, Michael B. Jebsen earned a total compensation of $597.5K as Former President and Chief Financial Officer at Tenax Therapeutics, a 50% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $175,844 |
|---|---|
| Option Awards | $71,709 |
| Salary | $349,981 |
| Total | $597,534 |
Jebsen received $350K in salary, accounting for 59% of the total pay in 2020.
Jebsen also received $175.8K in non-equity incentive plan and $71.7K in option awards.
Rankings
In 2020, Michael B. Jebsen's compensation ranked 10,525th out of 13,090 executives tracked by ExecPay. In other words, Jebsen earned more than 19.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,525 out of 13,090 | 20th |
Division Manufacturing | 4,514 out of 5,621 | 20th |
Major group Chemicals And Allied Products | 1,874 out of 2,254 | 17th |
Industry group Drugs | 1,640 out of 1,954 | 16th |
Industry Pharmaceutical Preparations | 1,211 out of 1,459 | 17th |
Source: SEC filing on April 28, 2022.
Jebsen's colleagues
We found one more compensation record of an executive who worked with Michael B. Jebsen at Tenax Therapeutics in 2020.
2020
Anthony DiTonno
Tenax Therapeutics